Clinical efficacy of hydralazine in chronic heart failure: One-year double-blind placebo-controlled study
- 1 October 1984
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 108 (4), 1001-1006
- https://doi.org/10.1016/0002-8703(84)90467-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placeboAmerican Heart Journal, 1982
- Results of long-term vasodilator therapy in patients with refractory congestive heart failure.Circulation, 1981
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- SUSTAINED EFFECT OF HYDRALAZINE IN LONG TERM TREATMENT OF CHFActa Medica Scandinavica, 1981
- Importance of Left Ventricular Chamber Size in Determining the Response to Hydralazine in Severe Chronic Heart FailureNew England Journal of Medicine, 1980
- Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction.Circulation, 1980
- Dose requirements of hydralazine in patients with severe chronic congestive heart failureThe American Journal of Cardiology, 1980
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Hemodynamic Effects of HydralazineActa Pharmacologica et Toxicologica, 1963